Amesite Operating Co
$ 2.41
1.26%
03 Dec - close price
- Market Cap 12,529,200 USD
- Current Price $ 2.41
- High / Low $ 2.41 / 2.30
- Stock P/E N/A
- Book Value 0.47
- EPS -0.83
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.72 %
- ROE -1.47 %
- 52 Week High 6.27
- 52 Week Low 2.00
About
Amesite Operating Co is an innovative technology firm based in Detroit, Michigan, specializing in AI-driven online learning solutions and course development. Harnessing advanced artificial intelligence, Amesite delivers personalized educational experiences that cater to the evolving demands of individuals and organizations, ultimately enhancing engagement and performance outcomes. By differentiating itself in the competitive digital education landscape, Amesite is well-positioned for sustained growth and expansion, offering a diverse range of products and services that address the needs of various industries.
Analyst Target Price
$7.00
Quarterly Earnings
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-09-29 | 2025-05-08 | 2025-02-12 | 2024-11-11 | 2024-08-28 | 2024-05-10 | 2024-02-14 | 2023-11-13 | 2023-09-29 | 2023-05-15 | 2023-02-10 | 2022-11-10 |
| Reported EPS | -0.2 | -0.1636 | -0.4017 | -0.3354 | -0.4645 | -0.5608 | -0.3562 | -0.3503 | -0.3731 | -0.11 | -0.72 | -0.06 |
| Estimated EPS | 0 | None | None | None | None | None | None | None | None | -0.08 | -0.48 | -0.04 |
| Surprise | -0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.03 | -0.24 | -0.02 |
| Surprise Percentage | None% | None% | None% | None% | None% | None% | None% | None% | None% | -37.5% | -50% | -50% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AMST
2025-11-09 07:05:00
Amesite Inc. (NASDAQ:AMST) stock surged 100% after reporting 63% revenue growth for its NurseMagic™ platform, driven by the launch of its census-based Enterprise subscription model. Enterprise sales have now surpassed B2C sales, indicating strong demand from post-acute care providers for scalable technology to ensure full reimbursement rates. The company also introduced an AI-powered automated form-fill solution for government forms, positioning itself to support new CMS mandates like the HOPE assessment.
2025-10-31 22:02:03
Amesite Inc. (NASDAQ: AMST) reported a 69% quarter-over-quarter revenue increase while simultaneously reducing expenses, driven by strong demand for its AI-powered solutions in post-acute healthcare. The company plans to launch the industry's first AI-powered electronic medical record (EMR) system for post-acute care by 2026, building on the success of its NurseMagic™ platform. This expansion and focus on AI innovation aim to improve healthcare efficiency and quality, leading to increased customer engagement and a growing market presence.
2025-10-31 22:02:03
Amesite (NASDAQ: AMST) reported a 69% quarter-over-quarter revenue increase in Q2 2026 and plans to launch an AI-powered Electronic Medical Record (EMR) for post-acute care by 2026. The company also highlighted significant customer adoption of its NurseMagic™ AI platform, coupled with a reduction in spending. These developments reflect Amesite's focus on operational discipline and AI-driven product innovation to meet growing demand in the healthcare sector.
2025-10-31 22:02:03
Amesite Inc. reported a significant 69% quarter-over-quarter revenue increase on October 30, 2025, while simultaneously reducing its spending. The company also announced plans to launch an AI-powered EMR platform for post-acute care by 2026, expanding its customer base and offerings in the U.S. These developments highlight high product satisfaction and operational efficiency improvements from rapid AI technology deployment.
2025-10-31 22:02:03
Amesite announced a 69% quarter-over-quarter revenue increase for Q2 2026 and plans to launch an AI-powered electronic medical record platform for post-acute care. The company's expansion into post-acute health businesses and focus on AI-powered process optimization are key drivers of its growth. Amesite's NurseMagic™ product is used by over 100 professions across 50 states and 21 countries, offering efficient healthcare documentation.
2025-09-11 10:40:00
Amesite Inc. announced a 63% revenue growth for its NurseMagic™ platform following the successful launch of its census-based Enterprise subscription model. This growth is driven by increasing demand from post-acute care providers seeking scalable technology to ensure full reimbursement rates and streamline compliance with upcoming regulatory changes like the HOPE assessment. Amesite's AI-powered solutions aim to reduce administrative burdens and provide a competitive edge in the rapidly expanding post-acute care market.
